JB Pharma

Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB ......

• Sreeja BiswasDebjyoti Roy